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A survey of the literature indicates that several chemicals whose reduced metabolites are capable of
undergoing redox cycling in biological systems also possess significant teratogenic properties when tested
in vivo. We have initiated investigations to determine whether the embryotoxic effects of such chemicals
could result from their redox cycling properties and whether redox cycling could be an important mech-
anism in chemical teratogenesis. In order to obviate the potentially confounding influences of maternal
factors, our initial studies have been performed with a whole embryo culture system with redox cycling
agents added directly to the culture medium. Several representative redox cycling agents including dox-
orubicin, paraquat, a series of nitroheterocycles, nitrosofluorene, and diethylstilbestrol (converted met-
abolically to redox cycling quinone/semiquinone radicals) have been investigated thus far. The nitrohet-
erocycles which bear nitro groups with comparatively high redox potentials produced a striking,
asymmetric defect involving primarily the right half of the prosencephalic and mesencephalic regions.
The effect was exacerbated under conditions oflow 02 tension. Accumulated data to date strongly suggest
that reduction of the nitro group is an essential feature in the embryotoxic mechanism. Quinones (dox-
orubicin, paraquat) and compounds metabolically converted to quinones (diethylstilbestrol) appeared to
produce embryotoxic effects via mechanisms not associated with redox cycling. Nitrosofluorene embry-
otoxicity was markedly exacerbated by changes in both intra- and extracellular glutathione levels, but
definitive dependence on a radical-mediated effect or redox cycling was not demonstrated.
Introduction
The biochemistry of chemical teratogenesis is a rel-
atively new area ofresearch that remains largely unex-
plored (1). Because of the intricate nature of
morphogenesis, the complexity of the problems asso-
ciated with such research is enormous and undoubtedly
discourages manypotentialinvestigators whootherwise
could contribute to a better understanding of mechan-
istic aspects. Thus much ofthe existinginformation con-
cerningchemically elicited developmental abnormalities
is still of a more descriptive than mechanistic nature.
Somerecent, fundamental scientific advances, however,
should encourage researchers to explore more seriously
the biochemical mechanisms whereby chemicals can
elicitdevelopmentalstructuralanomalies. Theevolution
of a successful whole embryo culturing system repre-
sents ahighly significant technological advance and now
permits investigators to study the effects of chemicals
on mammalian prenatal development in the absence of
potentially confounding maternal factors. The culture
system has also enabled a full recognition ofthe impor-
tance of both maternal and embryonic biotransforma-
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tion/bioactivation as critical determinants ofthe capac-
ity of chemicals to elicit defects (2). Ascertainment of
the identities of ultimate chemical dysmorphogenic
agents and of regulatory factors governing their gen-
eration during organogenesis will undoubtedly assist in
elucidating teratogenic mechanisms. Thus far, focus in
this research area has been on the cytochrome P-450-
dependent generation ofreactive intermediates byboth
extraembryonic (3-6) and embryonic (7-9) enzyme
sources. The purpose of this article is to discuss some
initial and preliminary findings with respect to cyto-
chrome P-450-independent embryonic systems that ap-
pearcapableofconvertingpotentialprodysmorphogenic
agents to theirultimate, biologically active forms. Most
of the drugs and chemicals in this category that have
been investigated thus far are those that can undergo
reduction by cellular reducing agents followed by reox-
idation by molecular oxygen (02). Reoxidation results
in the generation ofthe original, parent compound plus
superoxide anion (02) and, subsequently, highly reac-
tive metabolic derivatives of oxygen. Such chemicals
are also known as "redox cyclers" and may produce
biological effects via a variety of consequences of the
redox cycling process (10). Agents to be discussed will
include doxorubicin (Adriamycin), a series of hetero-
cyclic nitro compounds, certain nitroarenes, paraquat,
menadione, diethylstilbestrol (DES), nitrosofluorene,JUCHAU ET AL.
and2-acetylaminofluorene. Eachofthesesubstances (or
their respective metabolites) is known to be capable of
undergoing redox cycling in biological systems and has
also been studied in terms of its embryotoxicity in the
whole embryo culture system in our laboratories. It
should be re-emphasized that studies performed as of
this writing have only very recently been initiated and
many are thus ofa preliminary nature. They represent
the first reported attempts to investigate redox cycling
as a potential mechanism ofchemically induced terata.
Therefore, any conclusions drawn therefrom must be
regarded at present as strictly tentative and/or hypo-
thetical.
Redox Cycling: The Phenomenon
Redox cycling agents are chemicals that are capable
of undergoing single electron reduction reactions to
yield radical species (10). Such agents, in accordance
with their respective redox potentials, can accept elec-
trons from a variety of biological reducing agents in-
cluding reduced flavoproteins, reduced ferredoxin,
NADPH, NADH, reduced glutathione (GSH) and other
thiol-containing compounds, ascorbate, and probably
others. Enzymes known to catalyze such reactions are
frequently flavoproteins and include NADPH-cyto-
chrome P-450 reductase, xanthine oxidase, mitochon-
drial flavoproteins of the electron transport chain and
various other dehydrogenases. Frequently, redox cy-
clingxenobiotics accept electrons directly from reduced
flavoproteins.
In the presence of 02, the reduced organic chemical
can be reoxidized to the original parent compound by
donating a single electron to 02 thus converting it to
02. As long as both 02 and suitable reducing equiva-
lents (e.g., NADH, NADPH, GSH) are available, the
repetitive reduction and reoxidation reactions result in
the occurrence of a redox cycle and the process is re-
ferred to as "futile cycling." Clearly, this process (Fig.
1) could conceivably elicit cytotoxicity via depletion of
essential reducing equivalents, depletion of 02 (partic-
ularly if involved cells are already living under some-
what hypoxic conditions) or via interactions ofreactive
organic radical forms with critical biological macromo-
lecules. Interaction with small biomolecules is also a
potential damaging factor. GSH, for example, can com-
pete with 02 for nitro anion radicals (11), and redox
cycling can thus lead to depletion of the reduced form
ofcellularglutathione which constitutes one ofthe cell's
most important defenses against cytotoxic agents and
also subserves several highly important biological func-
tions (DNA synthesis, etc.). Such organic radicals can
also initiate lipid peroxidation reactions resulting in the
disruption or disorganization ofcellularmembranes and
ultimate cell death if sufficiently extensive.
In addition, generation of 02 leads to the formation
of hydrogen peroxide, both spontaneously and via the
catalytic action of superoxide dismutase. In the pres-
ence of transition metals (Fe2+, Cu+) and under other
appropriate conditions, hydrogenperoxide, inturn, can
be converted to highly reactive and potentially very
toxic hydroxyl radicals (- OH) and to singlet oxygen.
Under conditions in which 02 tensions are relatively
high, toxicity resulting from the generation ofhydroxyl
radicalsand/orfromthedepletionofimportantreducing
equivalents may predominate whereas, under condi-
tions oflow 02 tension, the major cause oftoxicity may
be an exacerbation of the hypoxic state and/or an in-
crease in the steady-state levels of organic radicals.
Radical species may bind covalently to critical macro-
molecules, initiate free radical-mediated reactions such
as lipid peroxidation or act via less well-established
mechanisms.
To what extent do redox cycling chemicals exist in
the modern environment? Prototype redox cycling
agents currentlyundergoingintensiveinvestigation are
aromatic nitro compounds (12) and quinone/quinonoids
(13). The aromatic nitro group can undergo single-elec-
tron reduction to yield nitro anion radicals that readily
reduce 02 to 02. Their capacity to undergo redox cy-
cling under conditions ofrelative hypoxia has been im-
plicated in their antimicrobial, radiosensitizing, carcin-
ogenic, andmutagenicproperties. Nitrocompounds can
be furtherreducedtothe corresponding nitroso analogs
Breoks
FIGURE 1. Metabolic pathways involved in the redox cycling of foreign organic chemicals (10).
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that may undergo redox cycling via conversion to ni-
troso anion radicals. Other radical species feasibly may
be generated during the ultimate reduction to primary
amines via the hydroxylamine, itself a reactive, toxic
intermediate.
Quinones may undergo either one- or two-electron
reduction reactions. The former, resulting in the for-
mation of radical semiquinones, represents a bioacti-
vation reaction due primarily to the reactivity of the
highly unstable semiquinone radical. The two-electron
reduction reactions, catalyzed by diaphorases, result in
the formation offully reduced hydroquinones which ap-
pear to be virtually inactive biologically and are nor-
mally regarded as detoxication processes. One of the
mostnotorious teratogenic chemicals, DES, appearsca-
pable ofproducing various deleterious biological effects
byvirtueofitsconversion toquinones and semiquinones
(14-16).
Other foreign organic chemicals that accept single
electrons in a stepwise fashion and are thus converted
to free radical intermediates potentially capable of re-
dox cycling are azo derivatives, nitroso compounds, N-
oxides, S-oxides, and polyhalogenated aliphatic hydro-
carbons (10). Carbonyl compounds also undergo dehy-
drogenase-catalyzed reduction reactions but these are
two-electron reduction reactions that do not involve the
production of radical intermediates. Living cells have
strongly negative redox potentials and are thus capable
of readily reducing each of these classes of chemicals.
A large number of factors are important determinants
ofthe quantitative generation ofbiologically active, re-
active intermediates from these chemicals. These in-
clude the redox potential ofthe reducible organic chem-
ical and the availability and activity of enzymes that
catalyze their respective reduction reactions. Also, the
energy status and02tensionofpotentiallyaffected cells
are clearly major factors. Under certain conditions, the
availability ofreducing equivalents and cellular concen-
trations of antioxidants (a-tocopherol, ascorbate, reti-
noids, GSH, uric acid, etc.) can also be of considerable
importance. Clearly, themannerinwhich theconceptus
handles such chemicals and the embryotoxicity caused
by these agents should be a matter of highest impor-
tance and interest.
Redox Cyclers as Teratogens in
Vivo
Which chemicals known or reputed to produce bio-
logical effects viaredox cycling are also reasonably well
established teratogens or embryotoxins? Some of the
more well known redox cyclers with reported terato-
genic properties are listed in Table 1. Currently, there
is no evident relationship between redox cycling and
the qualitative nature of malformations produced in
vivo. Clearly, many of the qualitative differences ob-
served thus far might be accounted for in terms ofdis-
positional factors. For example, a number of the com-
poundslistedinTable 1 donotcrossmembranesreadily,
whereas others are distributed rather evenly through-
out biological systems. Trypan blue (actively excluded
from most cells) is an azo dye reputed to produce ter-
atogenic effects by virtue of a specific action on the
visceral yolk sac (17). It would be ofinterest to deter-
mine whether other highly polar redox cyclers might
produce teratogenic effects similar in nature to those
elicited by trypan blue. Additionally, the toxic effects
of some redox cyclers (e.g., bleomycin, streptonigrin)
are exacerbated (10) by high 02 tension (tending to im-
plicate reactive oxygen metabolites) whereas the most
profound effects of other redox cyclers (e.g., misoni-
dazole, mitomycin c) are observed under conditions of
low 02 tension. Thus, even if it were to be presumed
that the chemicals listed in Table 1 produced their ter-
atogeniceffectsexclusivelyviaredoxcycling, onewould
nonetheless expect these agents to elicit a variety of
different abnormalities as a result ofdifferences in dis-
position and chemical properties. It must be borne in
mind, of course, that the teratogenic effects produced
may result from actions entirely independent of redox
cycling.
Effects of Redox Cyclers on
Cultured Whole Embryos
In order to eliminate the potentially confounding in-
fluences of maternal factors, we have elected to utilize
the whole embryo culture system to initiate investiga-
tions of biochemical mechanisms of chemically elicited
embryotoxicity including dysmorphogenesis. Advan-
tages of this system also include a greater capacity to
control the concentrations ofchemicals and/ortheirme-
tabolites that actually reach the various tissues of the
conceptus and the ability to stage the embryos accu-
rately prior to administration of the chemicals. Disad-
vantages include a lack of capacity to determine the
extent to which observed toxicities would persist be-
yond the period of culturing and the effort involved in
the performance of rigorous embryo-culture experi-
ments.
With respecttoredox cyclers and chemicals that may
be converted to such, we have initiated investigations
on several prototypic examples of various classes of
these agents. These include doxorubicin (adriamycin),
menadione, andparaquatasrepresentative ofquinones,
diethylstilbestrol as representative of a proquinone or
chemical which must be first converted metabolically to
a quinone, nifuroxime, furazolidone, nitrofurazone, ni-
trofurantoin, niridazole, 2-nitroimidazole, ronidazole,
metronidazole, 4-nitroimidazole, and4-methylniridazole
as representative ofnitroheterocycles, chloramphenicol
as a nitroarene, nitrosofluorene as an aromatic nitroso
compound and 2-acetylaminofluorene which is capable
of undergoing conversion to several different types of
reactive intermediates includingredox cyclers. Some of
the results obtained have been quite surprising, others
enigmatic, and still others have been those expected.
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Table 1. Examples of foreign organic chemicals which behave as a redox cyclers in biological systems and their reported
teratogenicity.
Chemical Teratogenic effects Species References
Quinones
Doxorubicin Multiple Rats (specific) (18)
Mitomycin C Skeletal Rats, mice (17)
Streptonigrin Eye, CNS, trunk, tail, limbs, etc. Rats (17)
Paraquat Costal cartilage defects Rats, hens (17)
Aromatic nitro compounds
Nitrofurazone Limbs, digits, tail Mice (19)
Nitrofurantoin Not defined Mice (20)
Misonidazole Limbs, eye, brain, palate Mice (21)
Nitrofen Eye, kidney, diaphragm Rats, mice (18)
Nitrobenzene Multiple Rats (18)
Azo compounds
Trypan Blue Hydrocephaly, spina bifida Several (17)
Evans Blue Brain, others Rats (17)
Congo Red Hydronephrosis, microophthalmia, Rats (17)
hydrocephalus
Aminoazobenzenes Skeletal, cleft palate Mice (18)
Miscellaneous
Bleomycin-Fe complex Multiple Rats, mice (18)
Quinones
Initial investigations of the effects of redox cyclers
on embryonic development in vitro began with a study
of doxorubicin (22). Somewhat surprisingly, the data
gathered in the studies argued against a role for redox
cycling in the observed embryotoxic effects produced
by the anthracycline antibiotic. Failure of several rad-
ical scavenging agents and antioxidants to ameliorate
the embryotoxic effects and a lack of an observable ef-
fect of changes in 02 tension of the culture medium
provided the principal arguments against the partici-
pation of redox cycling or of radical species. Interest-
ingly, inclusion of an S-9 fraction from methylcholan-
threne-induced rats in the culture system markedly
exacerbated the embryotoxicity and led us to speculate
that a methylcholanthrene-inducible, P-450-dependent
0-demethylase catalyzedtheformation ofthe4-hydroxy
derivative which is known to exhibit greater antitumor
activity than the parent 4-methoxy compound. Seem-
ingly, the embryotoxic effects produced by doxorubicin
were more closely akin to its antitumor properties
(which do not appear to depend on redox cycling) than
to its reputedly redox-dependent cardiotoxic effects.
Menadione, a quinone which undergoes reduction cat-
alyzed by the methylcholanthrene-inducible DT-dia-
phorase, did not affect the embryotoxicity of doxoru-
bicin (22) nor did it exhibit embryotoxicity by itself.
However, the highest concentration added to the cul-
ture medium was only 2 ,uM. Therefore, the embry-
otoxicity in vitro of this quinone will require further
evaluation.
Paraquat is a prototype redox cycler that is capable
of producing severe toxicity in the lungs. Like doxo-
rubicin, it is a quinone but is far more water-soluble
and thus diffuses across cellmembranes muchlessread-
ily. At 5 ,uM concentrations, this agent produced 100%
embryolethality in 12 embryos (unpublished), but at 1
,uM concentrations no effect on 10 embryos could be
detected. At concentrations above 10 ,uM it was appar-
ent that paraquat could produce severe effects on the
visceral yolk sac and, in view of its high polarity, it is
tempting to speculate that the embryotoxic effects ob-
servedwereduetoaspecificeffectonyolksacintegrity.
Such an effect might be analogous to that produced by
trypan blue (17), an azo dye and also a potential redox
cycler. Furtherstudies onthe mechanism ofthe invitro
embryo toxicity of paraquat will be of high interest.
Proquinones
Diethylstilbestrol, a synthetic diphenolic estrogen,
undergoes oxidative conversion to p-quinone and
p-semiquinone metabolites via direct (presumably per-
oxidative) oxidation ofthe p-phenolic groups (14). Con-
version to o-quinone and o-semiquinone intermediates
can occur via P450-dependent oxidation at carbons ad-
jacent to phenolic groups to yield catechols. The cat-
echols, inturn, are thenperoxidatively converted tothe
o-quinone and (presumably) o-semiquinone radical in-
termediates (15). Both of these pathways have been
implicated inthegenotoxic and carcinogeniceffectspro-
duced by DES (14,15). However, evidence obtained to
date in our laboratory indicates that the embryotoxic
effects of DES on cultured whole embryos are direct
and are neither a function of redox cycling nor bioac-
tivation via othermetabolic pathways (23). Preliminary
studies with the estrogen antagonist, tamoxifen, also
indicated that the effects are independent of interac-
tions with estrogen receptors. Since Z,Z-dienestrol, a
nonestrogenic metabolite, produced effects similar to
thoseobservedwithDES, theargumentforanestrogen
receptor-independent mechanism is strengthened.
Also, the similar effect of hexestrol, a synthetic non-
steroidal estrogen differing from DES only in lack of
the stilbene double bond, argues against the partici-
pation ofp-quinone/semiquinone intermediates. All re-
sultstodatetendtofostertheconceptthattheobserved
134REDOX CYCLERS AS TERATOGENS 135
effects of DES on whole cultured embryos are direct
and totally independent of metabolic activation. In ad-
dition, supplementation ofthe culturemediumwith var-
ious metabolic systems has failed thus far to influence
the embryotoxic effect ofDES. Therefore, as with dox-
orubicin, effects onthemorphologic development ofcul-
tured embryos appears independent ofredox cycling at
this stage of the research.
Nitroheterocycles
The discovery of a highly unusual asymmetric mal-
formation produced by niridazole (24,25), an antischis-
tosomal nitroheterocycle, led us to investigate a series
ofstructurallyrelated chemicalsinordertogaininsights
into the possible mechanism whereby the defect is elic-
ited. Studies thus far (26,27) have shown that the only
chemicals capable of producing the striking asymme-
trical malformation are those bearing a reducible nitro
group. All heterocyclic nitro compounds with redox po-
tentials higher than -0.480 (with the enigmatic excep-
tion of nitrofurantoin) produced the axial asymmetry
when cultured with whole rat embryos. A very large
number ofother chemicals that have undergone studies
in the whole embryo culture system have not exhibited
the capacity to produce the asymmetric defect. A good
correlation between single electron redox potentials of
nitro groups and capacity to elicit the defect was also
observed. The effect was also exacerbated by reducing
the 02 tension of the culture medium (28). The results
were highly compatible with the idea that the cultured
tissues of the conceptus are capable of reducing the
aromatic nitro groups to one or more reactive inter-
mediates which were more directly responsible for the
observed asymmetric defect. No exogenous enzyme
source was required for elicitation of the abnormality
and S-9 fractions in fact, tended to reduce the embry-
otoxicity (26). Interestingly, carbon monoxide tended
to ameliorate the effect, suggesting that a heme-depen-
dent reduction or reoxidation reaction was required for
generation of the reactive species. Previous investiga-
tions have shown (29,30) thatflavoproteins orevenfree,
reduced flavins can reduce aromatic nitro groups (e.g.,
p-nitrobenzoate) to hydroxylamines but that reduction
to the fully reduced primary amine (p-aminobenzoate)
required either a hemoprotein or free hemin as a cat-
alyst. Addition of N-acetylcysteine to the culture me-
dium did not appear to affect the incidence or severity
of defects produced (21) but lowering of intracellular
levels of GSH in tissues ofthe conceptus with buthion-
ine-S, R-sulfoximine (unpublished) markedly exacer-
bated the effect. Nevertheless, experiments designed
to rigorously test the possibility that redox cycling of
various potential nitroheterocycle intermediates is re-
sponsible for embryotoxic effects of nitroheterocycles
have notyetbeenperformed. Exacerbation ofthe effect
under conditions of lowered 02 tension tends to argue
against a mechanism involving the exhaustion ofintra-
cellular reducing equivalents because higher 02 tension
should exhaust these equivalents more effectively. It
also argues against a mechanism involving the gener-
ation ofhydroxyl radicals or otherreactive oxygen spe-
cies (singlet oxygen, hydrogen peroxide, etc.) since lev-
els ofthese species should be increased with increasing
02 tension. A mechanism involving localized depletion
oftissue 02 levels remains a possibility as does a more
direct effect ofintermediate organic radicals. At pres-
ent, the nitroheterocyclic compounds appear to be the
most probable candidates as examples of chemicals ca-
pable of producing embryotoxic effects via redox cy-
cling.
Aromatic Nitroso
Several metabolites of 2-acetylaminofluorene (AAF)
have been investigated as embryotoxins in whole em-
bryo cultures (6,31-33). A number of metabolites of
AAF have the potential to behave as redox cyclers al-
though this mechanism has not been seriously consid-
ered in terms of its carcinogenicity or mutagenicity.
Nitrosofluorene, an AAF metabolite, is a relatively po-
tent, direct-acting dysmorphogenic agent in vitro and
the possibility ofits conversion to redox cycling radical
intermediates is conceivable. Alterations of extracel-
lular as well as intracellular GSH levels also markedly
influences its dysmorphogenic effects (34). Again, how-
ever, much more investigation will be required to de-
termine whether redox cycling can be implicated even
partially. Certainly many other potential mechanisms
are conceivable.
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